Morningstar

Lonza Group Ltd LONN

Morningstar Rating
Unlock
Stock XSWX Rating as of
CHF 537.60 −0.80 (0.15%)
View Full Chart
As of Delayed Price Open

Company Report

View Archive

Price vs Fair Value

View History
LONN is trading at a 589% premium.
Price
CHF 538.40
Fair Value
CHF 637.00
Uncertainty
Medium
1-Star Price
CHF 215.90
5-Star Price
CHF 275.00
Economic Moat
Rxtwm
Capital Allocation
Vccdgnzv

Bulls Say, Bears Say

Bulls

The pharma biotech and nutrition segment is a sticky business with long-term contracts and high switching costs for its customers.

Bears

Lonza is vulnerable to facility closures whether from natural disasters or manufacturing issues, as a warning letter from the FDA can result in manufacturing delays or closures.

Show More

News

View All

Trading Information

Previous Close Price
CHF 538.40
Day Range
CHF 534.20–539.00
52-Week Range
CHF 308.60–589.40
Bid/Ask
CHF 537.40 / CHF 537.80
Market Cap
CHF 38.78 Bil
Volume/Avg
22,603 / 155,086

Key Statistics

Price/Earnings (Normalized)
33.41
Price/Sales
5.82
Dividend Yield (Trailing)
0.74%
Dividend Yield (Forward)
0.74%
Total Yield
3.76%

Company Profile

Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Large Growth
Total Number of Employees
17,834
Website
https://www.lonza.com

Competitors

Valuation

View More
Metric
LONN
02269
CTLT
Price/Earnings (Normalized)
 33.4120.61241.28
Price/Book Value
 4.151.623.03
Price/Sales
 5.823.702.49
Price/Cash Flow
 29.2521.0033.09
Price/Earnings
LONN
02269
CTLT

Financial Strength

Metric
LONN
02269
CTLT
Quick Ratio
 1.382.401.56
Current Ratio
 2.042.912.51
Interest Coverage
 6.8823.45−4.07
Quick Ratio
LONN
02269
CTLT

Profitability

Metric
LONN
02269
CTLT
Return on Assets (Normalized)
 5.18%7.48%0.39%
Return on Equity (Normalized)
 9.32%11.09%1.01%
Return on Invested Capital (Normalized)
 7.38%8.36%2.72%
Return on Assets
LONN
02269
CTLT

Diagnostics & Research Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
XkfbblyjRnctt$234.7 Bil
 Danaher Corp
DHR
VrpfcqbnmGhjbpg$198.9 Bil
 IQVIA Holdings Inc
IQV
BvyqnzlXvvcf$42.8 Bil
 Agilent Technologies Inc
A
JfkgjjdcQzdb$42.5 Bil
 IDEXX Laboratories Inc
IDXX
GfrnccrrnpWqqsq$42.1 Bil
 Mettler-Toledo International Inc
MTD
ZsckwjmbWlrvzbc$31.4 Bil
 Icon PLC
ICLR
JbtrqkwXfhtbb$23.7 Bil
 Waters Corp
WAT
QbmtgfwwzxCxmp$21.2 Bil
 Illumina Inc
ILMN
FdjtpfrvrHfkszp$20.7 Bil
 Labcorp Holdings Inc
LH
ZwtblcscvGcmyw$18.6 Bil

Sponsor Center